Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum.
about
OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimensPharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reportsAntiparasitic agent atovaquoneModulation of basophils' degranulation and allergy-related enzymes by monomeric and dimeric naphthoquinones.Antimalarial pharmacology and therapeutics of atovaquoneAtovaquone-proguanil for prophylaxis and treatment of malaria.Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory CoastAtovaquone/proguanil for the prophylaxis and treatment of malaria.Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study.Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administrationPlasmodium falciparum malaria and atovaquone-proguanil treatment failure.Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.Dosing rationale for fixed-dose combinations in children: shooting from the hip?
P2860
Q28831110-9096E919-F553-4544-A73C-4867E17DDC9DQ33978975-1B7A8656-5677-4F2F-A591-8C93B1366DE9Q34058304-153175B5-8ED9-4A7A-9D38-08073CD4ACA0Q34107885-CEC5AB9A-DCA1-4953-8AA2-E65CA6317FC5Q35108710-FEC3D727-385D-41F7-A2AC-442470465258Q35131253-47E66E72-9660-4CAF-BB87-E2D2E1BFACD2Q35201039-AB726A2B-F172-4861-B64A-490CCBAD940CQ35802755-CA5AF487-70C6-434D-8618-D9CD711474EFQ36249089-EC38F2D2-4872-4F35-AB32-C53A1909A500Q36322092-BA9878D3-9ADD-464F-A5B0-3B25B2295508Q36334960-E2DB8343-8C28-440C-B218-D014A2976974Q36628026-88A3906B-FB33-4A98-BC59-41FDEB7050A2Q37317559-BF0D0E32-523E-49FC-B324-C89BC307CAA7Q38627882-40BFE09A-CB35-490E-B964-8A024ADBBA38Q40571679-5FD6237D-6C7E-43BD-938E-857F71CBAF5FQ42565032-53EA85B2-2543-424D-8555-FD159744E13BQ43230430-9DF072D2-916A-4753-9914-0538FF3A79E1Q44160872-0A6E9495-C363-4386-A5D9-6F993B1C03CEQ44677507-122B70AA-7B46-436C-A9CF-DA55266C3C87
P2860
Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Population pharmacokinetics of ...... used by Plasmodium falciparum.
@en
Population pharmacokinetics of ...... used by Plasmodium falciparum.
@nl
type
label
Population pharmacokinetics of ...... used by Plasmodium falciparum.
@en
Population pharmacokinetics of ...... used by Plasmodium falciparum.
@nl
prefLabel
Population pharmacokinetics of ...... used by Plasmodium falciparum.
@en
Population pharmacokinetics of ...... used by Plasmodium falciparum.
@nl
P2093
P2860
P1476
Population pharmacokinetics of ...... used by Plasmodium falciparum.
@en
P2093
Canfield CJ
Hutchinson DB
P2860
P304
P356
10.1016/S0009-9236(97)90132-6
P407
P577
1997-05-01T00:00:00Z